Columbia University

Technology Ventures

Featured Funding Opportunities

In support of its mission to facilitate the transfer of inventions from academic research labs to the market, CTV publicizes funding opportunities that may be relevant to Columbia inventors as they conduct research and develop new technologies. For additional lists of funding opportunities, refer to these resources:

For further assistance with grant applications, see CTV's collection of IP and Entrepreneurship Language for Grant Applications.

Upcoming Opportunities

right
Deadline: 
Monday, October 28, 2019 - 5:00pm
The AIMS Awards were created to harness AI technology to facilitate and encourage drug discovery for all scientists.
right
Deadline: 
Wednesday, November 6, 2019 - 5:00pm
This strategic research alliance is a collaboration between Boston Biomedical, a wholly owned subsidiary of Sumitomo Pharma in Japan, and Columbia University, to advance research toward the development of disruptive technology platforms, novel science, and IND ready molecule(s) in the field of oncology.
right
Deadline: 
Friday, November 1, 2019 - 5:00pm
S2S is an invitation-only symposium for top scientists from leading research institutions to present their startup ideas and interact with leading investors and executives in the Boston biotechnology hub. 200+ anticipated attendees include entrepreneurs, biotech investors (Angels / VCs), pharma scouts, academic investigators, TTOs, etc.
 
The symposium is a setting to showcase research from selected scientists. Submissions are reviewed by a senior Advisory Group.
right
Deadline: 
Monday, November 4, 2019 - 5:00pm
The Columbia Life Science Accelerators: Lab-to-Market Programs are now accepting pre-proposal applications for their 2019-2020 awards cycle.
right
Deadline: 
Thursday, December 31, 2020 - 5:00pm

 

 

 

right
Deadline: 
Monday, October 21, 2019 - 5:00pm

Pfizer’s Centers for Therapeutic Innovation, or CTI, is a unique joint drug discovery model focused on collaborating with leading academic medical centers to translate and transform concepts into breakthroughs that change patients’ lives.

Past Funding Opportunities

right
Deadline: 
Monday, August 26, 2019 - 5:30pm to Monday, September 30, 2019 - 5:30pm

Almirall, S.A. is looking to sponsor research collaborations investigating novel targets, pathways, or therapeutic candidates relating to chronic immune-inflammatory diseases. Academics and university departments are invited to submit relevant, non‑confidential research proposals using the application form linked below. The team at Almirall are interested in sponsoring early-stage research programmes focused on target identification and validation, through to later stage applications progressing therapeutic opportunities into clinical settings.

right
Deadline: 
Wednesday, July 3, 2019 - 3:00pm to Tuesday, September 3, 2019 - 3:00pm

The Mark Foundation for Cancer Research (MFCR), The Leukemia & Lymphoma Society (LLS), and The Paul G. Allen Frontiers Group (PAFG) are proud to announce the Blood Cancer Discoveries Grant Program, a new research award program designed to encourage basic research, technological innovation, and informatics pipeline development that can lead to an understanding of blood cancer disease mechanisms, the development of improved methods for detecting and monitoring cancer progression, and the identification of novel therapeutic targets.

right
Deadline: 
Tuesday, June 11, 2019 - 1:45pm to Friday, June 21, 2019 - 5:00pm
Sanofi, a global biopharmaceutical company, is pleased to announce its 5th call for iAward pre-proposals. To date, the iAward program has attracted approximately 900 pre-proposals of which 230 have been invited back as Detailed Proposals.